论文部分内容阅读
ＥＢ病毒ＶＣＡ ＩｇＡ抗体血清学早期诊断鼻咽癌１９８６年通过鉴定 ,１９８８年获卫生部科技进步二等奖、国家科委三等奖。为了推广应用该成果 ,并评估其对鼻咽癌人群Ⅱ级预防意义 ,１９９１年～１９９８年我们先后在２４个市县３９１４４７人中推广应用 ,结果如下。１资料与
EBV VCA IgA antibody serological early diagnosis of nasopharyngeal carcinoma in 1986 through the identification of the Ministry of Health in 1988 by the second prize of scientific and technological progress, the third prize of the State Science and Technology Commission. In order to popularize the application of the results and evaluate its preventive effect on grade Ⅱ NPC patients, we have popularized 391,447 people in 24 cities and counties from 1991 to 1998 with the following results. 1 information and